glp-1 news october 9 2025 Looming drug patent expirations draw generics firms Designing GLP-1 delivery: structural perspectives

The program represents a differentiated approach in the increasingly competitive market for GLP-1-based weight management solutions.The new offering provides doses at 25% or less of typically prescribed maintenance levels, positioning it as an alternative for patients ...

Pricing, medications, results, and which GLP-1 provider wins in 2026.

Each serving gives 30 grams of protein designed for GLP-1 supportive nutrition plans

You receive a complete VIP membership operating system with templates, print friendly versions, and a tracker, grouped by purpose

Join our exclusive pre-launch waitlist today.

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.